Literature DB >> 8514412

Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.

M T Philipp1, M K Aydintug, R P Bohm, F B Cogswell, V A Dennis, H N Lanners, R C Lowrie, E D Roberts, M D Conway, M Karaçorlu, G A Peyman, D J Gubler, B J Johnson, J Piesman, Y Gu.   

Abstract

We demonstrate that Borrelia burgdorferi infection in the rhesus monkey mimics the early and early disseminated phases of human Lyme disease. Clinical, bacteriological, immunological, and pathological signs of infection were investigated during 13 weeks after inoculation of the spirochete. Three animals were given B. burgdorferi (strain JD1) by needle inoculations, six animals were exposed to the bite of B. burgdorferi-infected Ixodes dammini ticks, and three animals were uninfected controls. B. burgdorferi could be recovered from all animals that were given the spirochete. Bacteria were detectable until week 6 postinoculation (p.i.) in blood, until week 8 p.i. in skin biopsies, and at 10 weeks p.i. in the conjunctiva of one of two animals which developed conjunctivitis. Erythema migrans (EM) appeared in one of the three animals infected by needle inoculation and in five of the six animals infected by ticks. Deep dermal perivascular lymphocytic infiltrations (characteristic of human EM) were observed in all animals showing EM clinically. Both EM and conjunctivitis were documented concomitantly with the presence of the spirochete. Lethargy, splenomegaly, and cerebrospinal fluid pleocytosis were also noted in some animals, but the direct connection of these signs with the infection was not shown. The appearance rate of immunoglobulin M and immunoglobulin G antibodies to B. burgdorferi, as well as the antigen spectra recognized, were remarkably similar to those seen in humans. Serum antibodies from infected animals were able to kill B. burgdorferi in vitro in the presence of rhesus complement. The rhesus monkey model appears to be useful for the investigation of the immunology and pathogenesis of Lyme disease and for the development of immunoprophylactic, diagnostic, and chemotherapeutic protocols.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514412      PMCID: PMC280958          DOI: 10.1128/iai.61.7.3047-3059.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.

Authors:  S W Barthold; D H Persing; A L Armstrong; R A Peeples
Journal:  Am J Pathol       Date:  1991-08       Impact factor: 4.307

2.  Immunoblot analysis of antibody binding to polypeptides of Borrelia burgdorferi in children with different clinical manifestations of Lyme disease.

Authors:  D Nadal; C Taverna; W H Hitzig
Journal:  Pediatr Res       Date:  1989-10       Impact factor: 3.756

3.  An animal model for Lyme arthritis.

Authors:  S W Barthold; K D Moody; G A Terwilliger; R O Jacoby; A C Steere
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

Authors:  J L Coleman; J L Benach
Journal:  J Infect Dis       Date:  1987-04       Impact factor: 5.226

5.  Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.

Authors:  S K Kochi; R C Johnson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

6.  Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.

Authors:  S D Lovrich; S M Callister; J L Schmitz; J D Alder; R F Schell
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

7.  The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.

Authors:  J T Roehrig; J Piesman; A R Hunt; M G Keen; C M Happ; B J Johnson
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

8.  Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.

Authors:  S M Callister; R F Schell; K L Case; S D Lovrich; S P Day
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

9.  Cultivation and characterization of spirochetes from cerebrospinal fluid of patients with Lyme borreliosis.

Authors:  M Karlsson; K Hovind-Hougen; B Svenungsson; G Stiernstedt
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

10.  Infection of Syrian hamsters with Lyme disease spirochetes.

Authors:  R C Johnson; N Marek; C Kodner
Journal:  J Clin Microbiol       Date:  1984-12       Impact factor: 5.948

View more
  62 in total

1.  Feeding of ticks on animals for transmission and xenodiagnosis in Lyme disease research.

Authors:  Monica E Embers; Britton J Grasperge; Mary B Jacobs; Mario T Philipp
Journal:  J Vis Exp       Date:  2013-08-31       Impact factor: 1.355

Review 2.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

3.  Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.

Authors:  G H Giambartolomei; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement.

Authors:  J M Nowling; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

5.  OspE-related, OspF-related, and Elp lipoproteins are immunogenic in baboons experimentally infected with Borrelia burgdorferi and in human lyme disease patients.

Authors:  P Scott Hefty; Chad S Brooks; Amy M Jett; Gary L White; Stephen K Wikel; Ronald C Kennedy; Darrin R Akins
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Global transcriptome analysis of Borrelia burgdorferi during association with human neuroglial cells.

Authors:  Jill A Livengood; Virginia L Schmit; Robert D Gilmore
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

Review 7.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

8.  Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR.

Authors:  F B Cogswell; C E Bantar; T G Hughes; Y Gu; M T Philipp
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

Authors:  W S Probert; R B LeFebvre
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

10.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.